Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels | |
|---|---|---|---|---|
| 1 | 2 | |||
| Anaemia | x | |||
| Anorexia | x | |||
| Ataxia | x | x | ||
| Neoplasm malignant | x | x | ||
| Dizziness | x | x | ||
| Fatigue | x | |||
| Leukopenia | x | x | ||
| Nausea | x | x | ||
| Neoplasm | x | x | ||
| Neuropathy peripheral | x | x | ||
| Convulsion | x | |||
| Thrombocytopenia | x | x | ||
| Vertigo | x | x | ||
| Vomiting | x | x | ||
| Peripheral sensory neuropathy | x | |||
| Phosphatase alkaline increased | x | |||
| Neurological symptom | x | x | ||
| Neurotoxicity | x | x | ||
| Affective disorder | x | x | ||
| Myelosuppression | x | x | ||
| Ovarian cancer | x | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |